Aliquots - Research Briefs

October 21, 2016

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.

By Bill Snyder
October 20, 2016

Preparing for a return of pox

To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.

By Bill Snyder
October 12, 2016

Imaging probe for retinal disease

An imaging probe developed at Vanderbilt detects retinal inflammation early and may allow therapeutic intervention to prevent blindness.

By Leigh MacMillan
brain and lightning
October 11, 2016

Culprits in genetic epilepsies

Genetic variation in GABA-A receptors confers risk for inherited forms of epilepsy.

By Leigh MacMillan
October 7, 2016

Rheumatoid subtypes explored by PheWAS

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

By Paul Govern
October 6, 2016

Motoring to the tips of the brush border

New findings implicate a motor protein in the assembly of the brush border in the intestines and kidneys – a specialized surface that is critical for healthy organ function.

By Leigh MacMillan
September 29, 2016

BMI genotype and breast cancer risk

For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.
By Paul Govern
September 28, 2016

Targeting norovirus “noxiousness”

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea.
By Bill Snyder
September 23, 2016

Blood exposures for traditional healers

Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C.
By Paul Govern
September 22, 2016

H. pylori and anemia – new evidence

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.
By Bill Snyder
September 14, 2016

Restore T cells to fight leukemia

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.
By Bill Snyder
September 13, 2016

Risk factors for delirium

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.
By Leigh MacMillan
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.
By Leigh MacMillan